郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.

期刊：Archives of pharmacal research发表年份：2015作者：Hyeon Young Kim; Vithal B Jadhav; Dae Young Jeong; Woo Kyu Park; Jong-Hwan Song; Sunkyung Lee; Heeyeong Cho
阅读更多 →

药效评价Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.

期刊：Human molecular genetics发表年份：2015作者：Elisa Oppici; Sonia Fargue; Emma S Reid; Philippa B Mills; Peter T Clayton; Christopher J Danpure; Barbara Cellini
阅读更多 →

药效评价Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists.

期刊：Journal of medicinal chemistry发表年份：2015作者：Takashi Nagahara; Tsuyoshi Saitoh; Noriki Kutsumura; Yoko Irukayama-Tomobe; Yasuhiro Ogawa; Daisuke Kuroda; Hiroaki Gouda; Hidetoshi Kumagai; Hideaki Fujii; Masashi Yanagisawa; Hiroshi Nagase
阅读更多 →

药效评价The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.

期刊：Proteomics发表年份：2015作者：Stan Pasyk; Steven Molinski; Saumel Ahmadi; Mohabir Ramjeesingh; Ling-Jun Huan; Stephanie Chin; Kai Du; Herman Yeger; Paul Taylor; Michael F Moran; Christine E Bear
阅读更多 →